Neoplasms

All Conditions

Digestive System Diseases

Gland and Hormone Related Diseases

Symptoms and General Pathology

Rare Diseases

Cholangiocarcinoma

Pancreatic Neoplasms

Constriction, Pathologic

Cholestasis

Bile Duct Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Endocrine Gland Neoplasms

Gastrointestinal Diseases

Pancreatic Diseases

Endocrine System Diseases

Adenocarcinoma

Carcinoma

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Pathological Conditions, Anatomical

Biliary Tract Neoplasms

Bile Duct Diseases

Biliary Tract Diseases

Pancreatic Cancer

Bile Duct Cancer

Subjects who will receive radiofrequency ablation for pancreatico-biliary disorders, including malignancies.

Any probe that can conduct radiofrequency ablation within biliary ducts.

Radio Frequency ablation Probe

Michel Kahaleh, MD

Monica R Gaidhane, MD, MPH

William R Brugge, MD

The objective of this protocol is to establish a multicenter registry to evaluate the impact of radiofrequency ablation in the management of patients with pancreatico-biliary disorders including malignancies.

Bile duct cancer and pancreatic cancer are cancers that cannot be surgically removed. As the cancer grows, it blocks the drainage of the bile ducts that carry digestive juices from the gall bladder and pancreas to the small intestine. ERCP (endoscopic retrograde cholangiopancreatography) is often prescribed during which a tube with a tiny camera attached is inserted through the subject's mouth and advanced to a place in the small intestine where the bile duct empties. Through this scope the doctor enlarges the ducts with tiny balloons and places plastic or metal stents (straws) that help keep the bile ducts open so they can drain properly. However, due to the cancer, the stents are blocked eventually.

The purpose of this registry is to record information and evaluate the impact of radiofrequency ablation (RFA) of endoscopic radiofrequency ablation (RFA) probes in improving the management of bile duct cancer or pancreatic cancer by ablating the tissue in the bile duct(s) before the stent(s) are implanted. By using radiofrequency (RF) energy to heat the tissue in the duct(s) prior to stent(s) insertion, the surrounding tissue becomes coagulated and this may delay tumor growth and the time before the stent lumen becomes blocked. Thereby, allowing increased periods between the need for intervention and further stent implantation(s). The registry will evaluate the efficacy and safety of RFA procedures conducted for pancreatico-biliary disorders.

The safety and efficacy of various radio frequency ablation probes have been assessed in a series of studies. This multi-center registry has been initiated:

1. To document the immediate and post procedure clinical performance of radio frequency ablation in a 'real world' patient population requiring stent implantation for pancreaticobiliary disorders.
2. To assess the immediate and 6 months post procedure adverse event rate in patients.
3. To assess the impact of RFA on the life expectancy of patients suffering from pancreaticobiliary malignancies.

Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry

Efficacy Assessment- Change from Baseline in Bile Duct Stricture Diameter.

Safety Assessment - Number of Participants with Adverse Events, type, frequency and intensity.

Documentation of response rates,overall survival duration and overall stent occlusion-free duration.

Documentation of overall stent occlusion-free duration post intervention to highlight quality of life and reduction of interventional procedures.

Weill Medical College of Cornell University

Chief, Advanced Endoscopy

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry	NCT01439698	Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Bile Duct Obstr...	Radio Frequency...	18 Years -	Weill Medical College of Cornell University
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry	NCT01439698	Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Bile Duct Obstr...	Radio Frequency...	18 Years -	Weill Medical College of Cornell University

Spots Global Cancer Trial Database for radio frequency ablation probe